312 related articles for article (PubMed ID: 23617333)
21. RECURRENCE OF VITELLIFORM LESIONS ASSOCIATED WITH TEMPORARY VISION LOSS IN BEST VITELLIFORM MACULAR DYSTROPHY.
Wang YT; Tadarati M; Scholl HP; Bressler NM
Retin Cases Brief Rep; 2016; 10(1):63-71. PubMed ID: 26418331
[TBL] [Abstract][Full Text] [Related]
22. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.
Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D
Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013
[TBL] [Abstract][Full Text] [Related]
23. Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings.
Laich Y; Georgiou M; Fujinami K; Daich Varela M; Fujinami-Yokokawa Y; Hashem SA; Cabral de Guimaraes TA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2024 Jul; 131(7):845-854. PubMed ID: 38278445
[TBL] [Abstract][Full Text] [Related]
24. Unilateral vitelliform phenotype in autosomal recessive bestrophinopathy.
Cascavilla ML; Querques G; Stenirri S; Battaglia Parodi M; Querques L; Bandello F
Ophthalmic Res; 2012; 48(3):146-50. PubMed ID: 22584882
[TBL] [Abstract][Full Text] [Related]
25. Novel Presenting Phenotype in a Child With Autosomal Dominant Best's Vitelliform Macular Dystrophy.
Abdalla YF; De Salvo G; Elsahn A; Self JE
Ophthalmic Surg Lasers Imaging Retina; 2017 Jul; 48(7):580-585. PubMed ID: 28728185
[TBL] [Abstract][Full Text] [Related]
26. Anterior segment abnormalities and angle-closure glaucoma in a family with a mutation in the BEST1 gene and Best vitelliform macular dystrophy.
Wittström E; Ponjavic V; Bondeson ML; Andréasson S
Ophthalmic Genet; 2011 Nov; 32(4):217-27. PubMed ID: 21473666
[TBL] [Abstract][Full Text] [Related]
27. Novel BEST1 Mutations and Special Clinical Features of Best Vitelliform Macular Dystrophy.
Liu J; Zhang Y; Xuan Y; Liu W; Wang M
Ophthalmic Res; 2016; 56(4):178-185. PubMed ID: 27078032
[TBL] [Abstract][Full Text] [Related]
28. [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].
Perol J; Wolff B; Sahel JA; Le Mer Y
J Fr Ophtalmol; 2011 May; 34(5):281-6. PubMed ID: 21507509
[TBL] [Abstract][Full Text] [Related]
29. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U
Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.
Ruiz-Moreno O; Calvo P; Ferrández B; Torrón C
Acta Ophthalmol; 2012 Nov; 90(7):e574-5. PubMed ID: 22339886
[No Abstract] [Full Text] [Related]
31. Best's vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene.
Eksandh L; Bakall B; Bauer B; Wadelius C; Andréasson S
Ophthalmic Genet; 2001 Jun; 22(2):107-15. PubMed ID: 11449320
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis of the VMD2 gene in thai families with best macular dystrophy.
Atchaneeyasakul LO; Jinda W; Sakolsatayadorn N; Trinavarat A; Ruangvoravate N; Thanasombatskul N; Thongnoppakhun W; Limwongse C
Ophthalmic Genet; 2008 Sep; 29(3):139-44. PubMed ID: 18766995
[TBL] [Abstract][Full Text] [Related]
33. Novel mutation in BEST1 associated with retinoschisis.
Silva RA; Berrocal AM; Lam BL; Albini TA
JAMA Ophthalmol; 2013 Jun; 131(6):794-8. PubMed ID: 23572118
[No Abstract] [Full Text] [Related]
34. Course of visual decline in relation to the Best1 genotype in vitelliform macular dystrophy.
Booij JC; Boon CJ; van Schooneveld MJ; ten Brink JB; Bakker A; de Jong PT; Hoyng CB; Bergen AA; Klaver CC
Ophthalmology; 2010 Jul; 117(7):1415-22. PubMed ID: 20381869
[TBL] [Abstract][Full Text] [Related]
35. Dominant cystoid macular dystrophy.
Saksens NT; van Huet RA; van Lith-Verhoeven JJ; den Hollander AI; Hoyng CB; Boon CJ
Ophthalmology; 2015 Jan; 122(1):180-91. PubMed ID: 25267528
[TBL] [Abstract][Full Text] [Related]
36. Bilateral choroidal excavation in best vitelliform macular dystrophy.
Parodi MB; Zucchiatti I; Fasce F; Bandello F
Ophthalmic Surg Lasers Imaging Retina; 2014 Feb; 45 Online():e8-e10. PubMed ID: 24512759
[TBL] [Abstract][Full Text] [Related]
37. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FOR THE DETECTION OF SECONDARY CHOROIDAL NEOVASCULARIZATION IN VITELLIFORM MACULAR DYSTROPHY.
Stattin M; Ahmed D; Glittenberg C; Krebs I; Ansari-Shahrezaei S
Retin Cases Brief Rep; 2020; 14(1):49-52. PubMed ID: 28817420
[TBL] [Abstract][Full Text] [Related]
38. Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis.
Meunier I; Sénéchal A; Dhaenens CM; Arndt C; Puech B; Defoort-Dhellemmes S; Manes G; Chazalette D; Mazoir E; Bocquet B; Hamel CP
Ophthalmology; 2011 Jun; 118(6):1130-6. PubMed ID: 21269699
[TBL] [Abstract][Full Text] [Related]
39. Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2.
Schatz P; Klar J; Andréasson S; Ponjavic V; Dahl N
Ophthalmic Genet; 2006 Jun; 27(2):51-6. PubMed ID: 16754206
[TBL] [Abstract][Full Text] [Related]
40. A CASE OF CONE DYSTROPHY ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION.
Gulkilik G; Erdur SK; Eliacik M; Odabasi M; Ozsutcu M; Demirci G; Kocabora MS
Retin Cases Brief Rep; 2018 Spring; 12(2):111-114. PubMed ID: 27685498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]